Neumora Therapeutics, Inc. (NMRA) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-07-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-15 | 8-K | Material Agreement, Direct Financial Obligation, Item 2.05, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-29 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-11 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-05 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-21 | 8-K | Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-30 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-16 | 8-K | Listing Notice | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-03 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-13 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-15 | 8-K | Other Events | SEC |
| 2024-03-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.